DA Davidson raises CoreWeave stock price target on AI deals By Investing.com

DA Davidson raised CoreWeave’s price target to $175 from $125 while keeping a Buy rating, after the stock jumped to $102, up nearly 11% on the day and 26% over the past week. The move was driven by a new multi-year Anthropic agreement and Meta’s expanded $21 billion deal through 2032, which lifted CoreWeave’s pro-forma backlog to about $87.8 billion, with Meta representing roughly 40% of backlog. CoreWeave also priced $3.5 billion of convertible senior notes due 2032, up from the initially planned $3.0 billion.

Analysis

The market is starting to price CoreWeave less like a single-customer neocloud and more like a financing machine with embedded customer concentration risk. The Meta and Anthropic wins improve the visibility of future revenue, but the real second-order effect is that they validate a scarce-supply thesis for frontier compute: if the largest labs are locking in capacity years out, the bottleneck shifts from demand discovery to capital access and delivery execution. That favors the names that can warehouse GPUs and power fast, but it also means equity holders are increasingly underwriting a balance-sheet-intensive growth story.

The key risk is not demand collapse; it is margin compression from financing and customer leverage. A backlog that is heavily skewed to one hyperscale counterparty means pricing power may erode as soon as capacity normalizes or if those customers push for repricing in later years. The convert issuance is a subtle tell: management is effectively pre-funding the working capital and capex cycle, which can support growth in the next 6-18 months, but dilutes the equity value capture if the stock remains elevated while additional capital is repeatedly raised.

The market may be underestimating how much this helps adjacent picks-and-shovels names more than the platform itself. If frontier labs continue to dual-source compute across neoclouds and in-house builds, the benefits spill into GPU vendors, networking, power infrastructure, and data-center REITs; the incrementality is more durable there because they sell into the entire ecosystem rather than one contracted stack. Conversely, any sign that Meta or Anthropic internalize workloads faster than expected would hit CoreWeave first, because the multiple is already discounting years of flawless capacity monetization.

Near term, the stock can stay momentum-driven for weeks, but the next inflection is whether analysts start focusing on cash conversion and customer concentration instead of headline backlog. The most attractive setup is not chasing the common stock after a multi-day surge, but expressing the theme through lower-beta beneficiaries or through volatility structures that limit downside if the financing narrative cools.

Key Decisions for Investors

• Avoid chasing CRWV common after the sharp rerating; wait for a pullback or post-financing digestion over the next 2-4 weeks before adding, because the risk/reward is now more dependent on follow-through disclosures than on the initial contract headlines.
• Long META vs. short CRWV for a 3-6 month horizon: META gets AI optionality with far less balance-sheet leverage, while CRWV now carries concentration and funding risk; this is a cleaner way to own frontier AI demand without underwriting neocloud execution.
• Initiate a basket long in AI infrastructure beneficiaries (SMCI, networking/power-equipment proxies) on any CRWV weakness, as the capital spending signal should propagate through the supply chain over the next 1-2 quarters.
• For tactical exposure, buy CRWV call spreads rather than stock if entering on momentum over the next 1-2 weeks; upside can continue, but defined-risk structures are preferable given dilution and customer-concentration overhang.